These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8744620)

  • 1. Antiplatelet therapy and the prevention of thrombosis.
    Rodgers A; MacMahon S
    Aust N Z J Med; 1996 Apr; 26(2):210-5. PubMed ID: 8744620
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin, myocardial infarction, and gastrointestinal bleeding.
    Meade TW
    Lancet; 1999 Feb; 353(9153):676. PubMed ID: 10030366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin, myocardial infarction, and gastrointestinal bleeding.
    Cleland JG; Alamgir F
    Lancet; 1999 Feb; 353(9153):676. PubMed ID: 10030365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin for prevention of myocardial infarction.
    Mirvis DM
    J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for the prevention of cardiovascular morbidity.
    Sanchez-Ross M; Waller AH; Maher J; Klapholz M; Haider B; Kaluski E
    Minerva Med; 2010 Aug; 101(4):205-14. PubMed ID: 21030934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antiplatelet therapy on prevention of thrombotic diseases].
    Mase K; Yasunaga K
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):891-6. PubMed ID: 1833490
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and the risk of hemorrhagic stroke.
    Rosenberg R
    J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
    Mariani M; Biadi O
    Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
    [No Abstract]   [Full Text] [Related]  

  • 14. Is optimal antithrombotic therapy after myocardial infarction well defined?
    McAnulty JH
    Curr Cardiol Rep; 2001 Jan; 3(1):53-5. PubMed ID: 11139799
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts.
    Barnett HJ; Kaste M; Meldrum H; Eliasziw M
    Stroke; 1996 Apr; 27(4):588-92. PubMed ID: 8614912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiplatelet drugs in prevention and treatment of coronary heart disease: aspirin is obligatory, quite sufficient, and safe].
    Averkov OV
    Kardiologiia; 2003; 43(6):77-83. PubMed ID: 13677327
    [No Abstract]   [Full Text] [Related]  

  • 17. Rivaroxaban with or without aspirin for prevention of cardiovascular disease.
    Kruger PC; Eikelboom JW; Yusuf S
    Coron Artery Dis; 2018 Aug; 29(5):361-365. PubMed ID: 29346127
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 20. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.